Glycovariants of CA-125 for early detection of ovarian cancer |
Andrew Vickers |
Memorial Sloan Kettering Cancer Center |
PLCO |
Jun 12, 2025 |
2025-0037 |
A Predictive Multi-Marker Test to Improve Ovarian Cancer Diagnosis |
Andrew Stephens |
Cleo Diagnostics Ltd |
PLCO |
Jun 12, 2025 |
2025-0036 |
Longitudinal dynamics between adiposity, age, and visceral adipose tissue-related inflammation: implications for aggressive prostate cancer across the life course |
Fred Tabung |
The Ohio State University College of Medicine and Comprehensive Cancer Center |
PLCO |
Jun 12, 2025 |
2025-0033 |
Quantifying the proteome: exploratory associations with multiple myeloma |
Eleanor Watts |
National Cancer Institute |
PLCO |
Jun 12, 2025 |
2025-0032 |
Blood based biomarkers for early detection of lung cancer in those who have never smoked |
Edwin Ostrin |
University of Texas MD Anderson Cancer Center |
PLCO |
Jun 12, 2025 |
2025-0031 |
Machine Learning Multi-omics Spectroscopy Analysis of Serum for Early Detection of Pancreatic Cancer |
William Fisher |
Baylor College of Medicine |
PLCO |
Jun 12, 2025 |
2025-0013 |
Investigating pre-diagnostic blood proteomic profiles in relation to pancreatic ductal adenocarcinoma risk |
Ting Zhang |
National Cancer Institute |
PLCO |
Jun 12, 2025 |
2025-0006 |
Investigation of lifetime alcohol drinking with cancer and mortality risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Erikka Cronin |
Erikka Loftfield Cronin |
PLCO |
Jun 2, 2025 |
PLCO-1932 |
Metabolomic Profiles of Diabetes-Risk Reduction Diet and Cancer Risk |
Maryam Farvid |
George Mason University |
PLCO |
Apr 23, 2025 |
PLCO-1863 |
Metabolomic Profiles of Ultra-Processed vs. Unprocessed/Minimally Processed Foods in Cancer Risk Prediction: Examining Effect Modification by Smoking- and Obesity-Related Metabolites |
Maryam Farvid |
George Mason University |
PLCO |
Apr 23, 2025 |
PLCO-1882 |
Pan-Cancer Risks and Mortality: Multidimensional Associations with Lifestyle, Sociodemographics, and Diet/Nutrition Using the PLCO Database |
Yuxiang Luo |
Erasmus University Medical Center |
PLCO |
Apr 21, 2025 |
PLCO-1886 |
Blood Analysis-Driven Machine Learning for Ovarian Cancer Detection |
Ivan Shtepliuk |
Linköping University |
PLCO |
Apr 21, 2025 |
PLCO-1879 |
Pilot Study for serum and plasma samples |
Camargo Costanza |
NIH |
PLCO |
Apr 3, 2025 |
2025-9010 |
Genetic and environmental risk factors for multiple primary cancers |
Sonja Berndt |
National Cancer Institute |
PLCO |
Apr 2, 2025 |
PLCO-1873 |
Exploratory assessment of datasets |
Amanda Skarlupka |
National Cancer Institute - Division of Cancer Prevention |
PLCO |
Mar 21, 2025 |
PLCO-1865 |
Genome-Wide Association Study of Acute Myeloid Leukemia in Genomic Studies in Blood and Marrow Transplantation |
Filip Pirsl |
National Cancer Institute |
PLCO |
Mar 18, 2025 |
PLCO-1861 |
A European “shield” against colorectal cancer (ONCOSCREEN) |
Amal Elgammal |
Amal Elgammal |
PLCO |
Mar 18, 2025 |
PLCO-1845 |
Development and Validation of a Machine Learning Model for Predicting Sentinel Lymph Node Metastasis in Melanoma Patients |
Diego Mendez |
Hospital El Pino |
PLCO |
Mar 18, 2025 |
PLCO-1855 |
Sample selection for multiple myeloma proteomics study |
Eleanor Watts |
National Cancer Institute |
PLCO |
Mar 18, 2025 |
PLCO-1856 |
Enhancing Decision-Making with Real-World Evidence: Population Adjustments, Outcome Prediction, and Cost-Effectiveness Analytics |
Reut Lanyado |
Reut Lanyado |
PLCO |
Mar 12, 2025 |
PLCO-1849 |